Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.061 | 0.7 |